出 处:《中国骨与关节杂志》2017年第12期883-888,共6页Chinese Journal of Bone and Joint
基 金:2013年度卫生行业科研专项项目(201302007)
摘 要:目的探讨加速康复外科模式下初次单次全髋关节置换术(total hip arthroplasty,THA)术中优化鸡尾酒疗法(罗哌卡因配伍氨甲环酸切口周围局部注射)的安全性和有效性。方法前瞻性纳入行加速康复外科模式下初次单次THA患者80例,根据术中鸡尾酒疗法方案,以数字表法随机分为试验组(40例,缝皮前切口周围局部浸润注射罗哌卡因200 mg+氨甲环酸80 ml混合溶液100 ml)和对照组(40例,缝皮前切口周围局部浸润注射罗哌卡因200 mg+生理盐水80 ml混合溶液100 ml)。主要指标为最大血红蛋白下降值、总失血量、输血率、视觉模拟疼痛评分(visual analogue scale,VAS);次要指标为补救镇痛率、术后并发症发生率、术后住院日及术后2周血栓发生事件。结果最大血红蛋白下降值:试验组(24.3±9.9)g/L,对照组(24.1±10.9)g/L,差异无统计学意义(P>0.05)。总失血量:试验组(737.4±399.0)ml,对照组(730.1±401.3)ml,差异无统计学意义(P>0.05)。术侧髋关节活动时VAS疼痛评分:术前、术后当天、术后第1、2天,试验组分别为(4.5±0.7)分、(1.7±0.5)分、(1.6±0.6)分、(1.2±0.4)分;对照组分别为(4.5±0.7)分、(1.5±0.5)分、(1.6±0.6)分、(1.1±0.4)分,差异无统计学意义(P>0.05)。术后补救镇痛率:试验组为12.5%,对照组为7.5%,差异无统计学意义(P>0.05)。术后并发症发生率:试验组为10.0%,对照组为17.5%,差异无统计学意义(P>0.05)。术后住院日:试验组为(2.5±0.6)天,对照组为(2.4±0.7)天,差异无统计学意义(P>0.05)。两组均无1例输血,术后2周彩超检查无1例下肢深静脉血栓发生。结论加速康复外科模式下初次单侧THA术后失血少、疼痛轻、康复快,术中优化鸡尾酒疗法虽然是安全的,但其有效性尚需进一步研究证实。Objective To explore the safety and efficacy of the optimized cocktail therapy [ local injection of ropivacaine with tranexamic acid ( TXA ) before incision closure ] in primary unilateral total hip arthroplasty ( THA ) with enhanced recovery after surgery ( ERAS ) program. Methods A total of 80 patients who underwent primary unilateral THA with ERAS program were randomly divided into the experimental group ( 40 patients ) that received local injection of 200 mg ropivacaine with 80 ml TXA before incision closure, and control group ( 40 patients ) that received local injection of 200 mg ropivacaine with 80 ml normal saline relatively. The maximum hemoglobin ( Hb ) drop, total blood loss, transfusion, visual analogue scale ( VAS ) pain score, the incidence for rescue analgesia, postoperative complications, length of stay, and embolism events during 2 weeks' follow-up were recorded and compared. Results In the experimental group, the maximum Hb drop was ( 24.3 ± 9.9 ) g / L, total blood loss was ( 737.4 ± 399.0 ) ml, which were not statistically significantly different from that in the control group ( 24.1 ± 10.9 ) g / L, ( 730.1 ± 401.3 ) ml ( P 〉 0.05 ). VAS pain score in mobilization preoperatively, on the day of surgery, and on postoperative day 1 and 3 in the experimental group were respectively on average ( 4.5 ± 0.7 ), ( 1.7 ± 0.5 ), ( 1.6 ± 0.6 ) and ( 1.2 ± 0.4 ), while in the control group were ( 4.5 ± 0.7 ), ( 1.5 ± 0.5 ), ( 1.6 ± 0.6 ) and ( 1.1 ± 0.4 ). VAS pain scores at each time points were not statistically significantly different between the 2 groups ( P 〉 0.05 ). The incidence for rescue analgesia and the rate of postoperative complications in the experimental group were 12.5% and 10.0%, while that were 7.5% and 17.5% in the control group. The differences were not statistically significant ( P 〉 0.05 ). There were no statistically significantly differences in postoperative length of stay
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...